These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23966522)

  • 21. Challenges of standardized continuous quality improvement programs in community pharmacies: the case of SafetyNET-Rx.
    Boyle TA; MacKinnon NJ; Mahaffey T; Duggan K; Dow N
    Res Social Adm Pharm; 2012; 8(6):499-508. PubMed ID: 22421196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brazilian National System for the Monitoring and Improvement of Compounding Practices: program outcomes.
    de Souza HG; Favaro A; Andrade AL; Gomes LY; Garcez Mdo C
    Int J Pharm Compd; 2012; 16(2):98-102. PubMed ID: 23050320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specialty compounding for improved patient care: 2006 national survey of compounding pharmacists.
    Huffman DC; Holmes ER
    Int J Pharm Compd; 2008; 12(1):74-82. PubMed ID: 23969574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insurance for the compounding pharmacy business, part 2: what, when, and where.
    Baker KR
    Int J Pharm Compd; 2008; 12(6):514-23. PubMed ID: 23969929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-prescribing errors identified in a compounding pharmacy: a quality-improvement project.
    Reed-Kane D; Kittell K; Adkins J; Flocks S; Nguyen T
    Int J Pharm Compd; 2014; 18(1):83-6. PubMed ID: 24881345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical care: pharmacy's mission for the 1990s.
    Penna RP
    Am J Hosp Pharm; 1990 Mar; 47(3):543-9. PubMed ID: 2316539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical counseling: Between evidence-based medicine and profits.
    Egorova SN; Akhmetova T
    Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insurance for the Compounding Business, Part 1: Who is Covered?
    Baker KR
    Int J Pharm Compd; 2008; 12(5):420-4. PubMed ID: 23969866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obtaining accreditation by the pharmacy compounding accreditation board, part 1: an overview.
    Cabaleiro J
    Int J Pharm Compd; 2007; 11(4):297-8. PubMed ID: 23974788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Building capacity to implement cognitive pharmaceutical services: Quantifying the needs of community pharmacies.
    Feletto E; Wilson LK; Roberts AS; Benrimoj SI
    Res Social Adm Pharm; 2010 Sep; 6(3):163-73. PubMed ID: 20813330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany.
    Berger K; Eickhoff C; Schulz M
    J Clin Pharm Ther; 2005 Feb; 30(1):45-57. PubMed ID: 15659003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Providing patient care in community pharmacies in Australia.
    Benrimoj SI; Roberts AS
    Ann Pharmacother; 2005 Nov; 39(11):1911-7. PubMed ID: 16219897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unresolved issues in the future of pharmacy.
    Hepler CD
    Am J Hosp Pharm; 1988 May; 45(5):1071-81. PubMed ID: 3041805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-prescription errors and their resolution in a community compounding pharmacy.
    Reed-Kane D; Vasquez K; Pavlik A; Peragine J; Sandberg M
    Int J Pharm Compd; 2014; 18(2):159-61. PubMed ID: 24881120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality-control analytical methods: a guide to quality control testing for the compounding pharmacist.
    Zolner WJ
    Int J Pharm Compd; 2006; 10(4):281-2. PubMed ID: 23974260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harvey A. K. Whitney Lecture. Shifting pharmacy's paradigm.
    Ivey MF
    Am J Hosp Pharm; 1993 Sep; 50(9):1869-74. PubMed ID: 8135232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacy screening project--an evaluation of pharmacy-based screening programmes.
    Flobbe K; IJsselmuiden CB; Rheeder P; Gerber JJ; Lubbe M
    S Afr Med J; 1999 Sep; 89(9):980-6. PubMed ID: 10554636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.